<DOC>
	<DOC>NCT01101919</DOC>
	<brief_summary>This study is designed to evaluate the levels of CP-690,550 in the blood of healthy Chinese subjects following both single doses and multiple doses of drug.</brief_summary>
	<brief_title>CP-690,550 Pharmacokinetics In Healthy Chinese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Healthy Chinese Volunteers No evidence of active or latent or inadequately treated infection with Mycobacterium tuberculosis (TB) Clinically significant infections within the past 3 months Positive screening test for hepatitis B surface antigen, antihepatitis C antibody, or human immunodeficiency virus Pregnant or nursing women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>